老年人喉癌合并糖尿病80例手术治疗  

Analysis of the efficacy of surgical treatment for 80 elderly laryngeal cancer patients with type 2 diabetes

作　　者：马健[1] 牟军伟[1] 

机构地区：[1]济宁医学院附属日照市人民医院耳鼻咽喉头颈外科,山东省日照276826

出　　处：《中国基层医药》2011年第15期2060-2061,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的探讨手术治疗老年喉癌合并糖尿病的临床疗效。方法对80例喉癌合并糖尿病的患者择期进行手术治疗，随机分为观察组40例和对照组40例，对照组在围术期口服降糖药，观察组在围术期采用胰岛素泵持续皮下胰岛素输注控制血糖。比较两组患者的术中血糖水平及术后血糖水平、手术耐受性、喉瘘的发生率、住院时间以及术后3年、5年的生存率。结果观察组术中血糖水平及术后血糖水平、手术耐受性均显著优于对照组（P〈0．05）；观察组的喉瘘的发生率、住院时间均显著少于对照组（P〈0．05）。结论围手术期控制血糖可提高手术耐受性，减少术后并发症。Objective To investigate the clinical curative effect of the surgical treatment elderly laryngeal cancer patients with type 2 diabetes. Methods 80 cases laryngeal cancer patients with type 2 diabetes, admitted to surgery 80 cases were randomly divided into observation group and control group. The control group was given perioperative oral glucose-lowering medications, the observation group in perioperative adopted continuously subcutaneous insulin pump infusion to control blood sugar. Compared two sets of patients intraoperative blood glucose level and postoperative blood sugar level, surgical tolerability, the incidence rate of laryngostomic fistula, the length of time and after 3 years,5 years of survival rate. Results The observation group intraoperative blood glucose level and postoperative blood sugar level, surgical tolerability,postoperative in 3 and 5 years survival rates were significantly better than control group（P 〈 0.05）, In the observation group the incidence rate of laryngostomic fistula, the length of time were significantly less than control group （ P 〈 0.05 ）. Conclusion Perioperative period by strengthening the control blood sugar treatment could be inside short time make a patient blood glucose levels drop to the desired level, decrease postoperatie complications,ensure therapeutic effect.

关 键 词：老年人 喉肿瘤 2型糖尿病 外科手术 

分 类 号：R587[医药卫生—内分泌] R73[医药卫生—内科学]